Merck (MRK) Dividends payables (2009 - 2026)

Merck has disclosed Dividends payables across 18 years of filings, most recently posting $2.1 billion for Q1 2026.

• In Q1 2026, Dividends payables rose 3.18% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (up 3.18% YoY), while the FY2025 annual figure was $2.1 billion, up 2.69% from the prior year.
• Dividends payables was little changed at $2.1 billion in Q1 2026, from $2.1 billion in the prior quarter.
• Over the last five years, Dividends payables for MRK reached as high as $2.1 billion in Q1 2026 and fell as low as $1.8 billion in Q2 2022.
• The 5-year median for Dividends payables is $2.0 billion (2024), against an average of $2.0 billion.
• Annual changes were most pronounced in 2023 — Dividends payables advanced 7.68% — and 2025, when it increased 2.69%.
• A 5-year view of Dividends payables shows it stood at $1.9 billion in 2022, then increased by 5.36% to $2.0 billion in 2023, then grew by 4.99% to $2.1 billion in 2024, then grew by 2.69% to $2.1 billion in 2025, then rose by 0.14% to $2.1 billion in 2026.
• According to Business Quant data, Dividends payables over the past three periods registered $2.1 billion, $2.1 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.